People

See all

Pierre Gaudriault

Microphysiological System Platform Development

Cherry Biotech (CHB)

About Pierre

PharmD – PhD. Pierre Gaudriault has the role of Chief Business Development and coordinates the European Project management at the level of the company Cherry Biotech. Pierre completed a PharmD, a MSc in University Paris Descartes followed by a PhD, focused on toxicity effect of a mixture of chemicals on the endocrine function of the testis. Pierre is also part of Cherry shareholder for 9 years.

Research

In this role, research priorities are focussed on product development, platform characterisation and prototyping of novel applications using the technology developed at Cherry Biotech. The company aim is to develop a standardised organ-on-chip (OOC) platform that can be integrated into exisitng academic and industrial workflows to control media enrichment, temperature and model shear stress (among other biophysical parameters). Within the PLAST CELL project, this research is being used to develop an industrially compatible approach for cell confinement that can remain low-cost, highly reproducible and simple to integrate with existing academic / pharmaceutical laboratoires.